AI in Indian Ophthalmology: Preventing Diabetic Retinopathy at Scale
Diabetes is widespread in India, and one of its most serious complications is diabetic retinopathy, damage to the blood vessels in the retina that can lead to vision loss. This article explains how AI-based screening helps detect the condition early, how screening programs are organised, and what people with diabetes can do to protect their sight.
Understanding Diabetic Retinopathy
High blood sugar over long periods can weaken the tiny blood vessels in the retina, causing them to leak, bleed or grow abnormally. In the early stages there are often no symptoms at all, which is why many people do not realise anything is wrong until their vision is already affected.
The good news is that early detection makes a real difference. Timely treatment, along with good control of blood sugar, blood pressure and cholesterol, can slow or prevent serious vision loss. The challenge is reaching the very large number of people with diabetes who need regular eye checks.
How AI Screening Works
Screening starts with a photograph of the back of the eye, taken with a retinal camera. Some newer cameras are portable or smartphone-based and can be operated by trained technicians rather than eye doctors. AI software analyses the image and classifies it, typically as no retinopathy, mild disease or referable disease that needs specialist attention.
India has been an important testing ground for these tools, with several eye hospitals and research groups evaluating AI screening in real clinics. The approach allows screening to happen in diabetes clinics, pharmacies, primary health centres and outreach camps, not just in eye hospitals.
Making Screening Work at Scale
Technology alone is not enough. Successful programs pay attention to the whole pathway, from the first photograph to treatment. Key practices include:
- Integrating eye screening into routine diabetes check-ups so patients do not need separate visits.
- Training technicians to capture clear images, sometimes using eye drops to widen the pupils.
- Setting up fast referral links to ophthalmologists for patients flagged by the software.
- Following up with patients who miss referrals, through phone calls or community health workers.
- Regularly auditing the software's results against specialist grading.
AI tools also have limitations. Poor-quality images, cataracts or small pupils can make analysis difficult, and the software usually focuses on retinopathy rather than every possible eye condition. Ungradable images should always be referred for a full examination.
People with diabetes should have their eyes checked regularly as advised by their doctor, and anyone noticing blurred vision, floaters or sudden changes should see an ophthalmologist promptly.
Protecting Vision for Millions
AI-based retinal screening makes it possible to check far more people with diabetes than specialists alone could manage. Its impact depends on good image capture, quick referrals and consistent follow-up. Combined with good diabetes control, widespread screening can prevent a great deal of avoidable blindness.